Cedar Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-6,403
Closed -$953K 119
2020
Q3
$953K Buy
6,403
+777
+14% +$115K 0.32% 89
2020
Q2
$791K Buy
5,626
+503
+10% +$73.3K 0.3% 89
2020
Q1
$672K Sell
5,123
-835
-14% -$118K 0.32% 85
2019
Q4
$869K Buy
5,958
+1,445
+32% +$196K 0.4% 82
2019
Q3
$584K Buy
4,513
+470
+12% +$61.9K 0.27% 105
2019
Q2
$563K Sell
4,043
-1,502
-27% -$208K 0.24% 105
2019
Q1
$775K Sell
5,545
-387
-7% -$51.8K 0.34% 79
2018
Q4
$766K Buy
5,932
+694
+13% +$96.8K 0.39% 69
2018
Q3
$724K Sell
5,238
-666
-11% -$88.5K 0.28% 84
2018
Q2
$716K Buy
5,904
+1,221
+26% +$152K 0.32% 68
2018
Q1
$600K Buy
4,683
+3,178
+211% +$430K 0.28% 63
2017
Q4
$210K Sell
1,505
-188
-11% -$26.2K 0.1% 132
2017
Q3
$220K Sell
1,693
-335
-17% -$44.4K 0.1% 105
2017
Q2
$268K Sell
2,028
-798
-28% -$102K 0.12% 83
2017
Q1
$352K Buy
+2,826
New +$338K 0.15% 51

Other funds holding JNJ

Cedar Capital's JNJ Position: Q4 2020 in Review

Cedar Capital sold out of Johnson & Johnson (JNJ) in Q4 2020, closing a stake of 6,403 shares — an estimated $953K sold.

Cedar Capital first reported a position in JNJ in Q1 2017 and held it in 15 quarters. The position peaked at $953K in Q3 2020. 3,265 funds tracked by Wall St. Rank hold JNJ as of Q4 2020.

  • Cedar Capital reported no remaining Johnson & Johnson position as of Q4 2020 after selling out during the quarter.
  • Cedar Capital sold 6,403 Johnson & Johnson shares in Q4 2020, an estimated $953K.
  • Cedar Capital first reported a position in Johnson & Johnson in Q1 2017 and held it in 15 quarters.
  • Cedar Capital's Johnson & Johnson position peaked at $953K in Q3 2020.
  • 3,265 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2020.

Based on Cedar Capital's 13F filing for Q4 2020, filed 5 Feb 2021.